Recombinant multi-species VPREB1/CD179a protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine VPREB1/CD179a protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene belongs to the immunoglobulin superfamily and is expressed selectively at the early stages of B cell development, namely, in proB and early preB cells. This gene encodes the iota polypeptide chain that is associated with the Ig-mu chain to form a molecular complex which is expressed on the surface of pre-B cells. The complex is thought to regulate Ig gene rearrangements in the early steps of B-cell differentiation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2015]
The Alternative Names of target: VPREB1, CD179a,Immunoglobulin iota chain,CD179 antigen-like family member A, Protein VPreB1, V(pre)B protein (VpreB protein),IGI,IGVPB,VPREB,CD179a

Target products collectionGo to VPREB1/CD179a products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1590-Ab-1/ GM-Tg-hg-SE1590-Ab-2 Human VPREB1/CD179a protein Human
GM-Tg-rg-SE1590-Ab-1/ GM-Tg-rg-SE1590-Ab-2 Rat VPREB1/CD179a protein Rat
GM-Tg-mg-SE1590-Ab-1/ GM-Tg-mg-SE1590-Ab-2 Mouse VPREB1/CD179a protein Mouse
GM-Tg-cynog-SE1590-Ab-1/ GM-Tg-cynog-SE1590-Ab-2 Cynomolgus/Rhesus macaque VPREB1/CD179a monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1590-Ab-1/ GM-Tg-felg-SE1590-Ab-2 Feline VPREB1/CD179a protein Feline
GM-Tg-cang-SE1590-Ab-1/ GM-Tg-cang-SE1590-Ab-2 Canine VPREB1/CD179a protein Canine
GM-Tg-bovg-SE1590-Ab-1/ GM-Tg-bovg-SE1590-Ab-2 Bovine VPREB1/CD179a protein Bovine
GM-Tg-equg-SE1590-Ab-1/ GM-Tg-equg-SE1590-Ab-2 Equine VPREB1/CD179a protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1590-Ab-1/ GM-Tg-hg-SE1590-Ab-2; GM-Tg-rg-SE1590-Ab-1/ GM-Tg-rg-SE1590-Ab-2;
GM-Tg-mg-SE1590-Ab-1/ GM-Tg-mg-SE1590-Ab-2; GM-Tg-cynog-SE1590-Ab-1/ GM-Tg-cynog-SE1590-Ab-2;
GM-Tg-felg-SE1590-Ab-1/ GM-Tg-felg-SE1590-Ab-2; GM-Tg-cang-SE1590-Ab-1/ GM-Tg-cang-SE1590-Ab-2;
GM-Tg-bovg-SE1590-Ab-1/ GM-Tg-bovg-SE1590-Ab-2; GM-Tg-equg-SE1590-Ab-1/ GM-Tg-equg-SE1590-Ab-2
Products Name VPREB1/CD179a protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name VPREB1/CD179a
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine VPREB1/CD179a protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.